Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A
Robert Sidonio, Jr., MD, MSc, discusses treatment considerations and ideal candidates for factor VIII and emicizumab in patients with hemophilia A.
EP: 1.The Role of Prophylactic Therapy in Hemophilia A
EP: 2.Considerations for Prophylaxis in Patients With Hemophilia A
EP: 3.Selecting Prophylactic Therapy in Hemophilia A
Now Viewing
EP: 4.Ideal Candidates for Factor VIII and Emicizumab for Hemophilia A
EP: 5.Role of Specialty Pharmacies in the Management of Hemophilia A
EP: 6.Specialty Pharmacy Dispensing Process for Factor VIII and Emicizumab for Hemophilia A
EP: 7.Financial Challenges Associated With Prophylactic Treatment for Hemophilia A
EP: 8.Overcoming Barriers in Specialty Pharmacy for Treatment of Hemophilia A
EP: 9.Reflections on the Evolving Space of Prophylaxis in Hemophilia A
Related Videos
